ANG Lifesciences India Limited (BOM:540694)

Market Cap	339.52M -39.8%
Revenue (ttm)	922.09M -14.4%
Net Income	-122.05M
EPS	-9.39
Shares Out	13.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,613
Average Volume	3,112
Open	25.18
Previous Close	26.24
Day's Range	25.00 - 26.49
52-Week Range	21.03 - 40.48
Beta	-0.25
RSI	46.23
Earnings Date	Feb 14, 2026

About ANG Lifesciences India

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and ...

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Employees: 412
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540694

Financial Performance

In fiscal year 2025, ANG Lifesciences India's revenue was 928.47 million, a decrease of -36.45% compared to the previous year's 1.46 billion. Losses were -124.13 million, 22.4% more than in 2024.